Skip to main content
NIH funding notice PAR-23-119

Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)

Closed on January 7, 2025.

Posted
April 11, 2023
Close date
January 7, 2025
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

20 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $6,742,171 in first-year total cost, median $370,808.

Most frequent study sections

  1. Kidney and Urological Systems Function and Dysfunction Study Section[KUFD]8
  2. Pathobiology of Kidney Disease Study Section[PBKD]4
  3. Emerging Imaging Technologies and Applications Study Section[EITA]2
  4. Basic Biology of Blood, Heart and Vasculature Study Section [BBHV]1
  5. Drug Discovery and Molecular Pharmacology B Study Section[DMPB]1

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA, SAN FRANCISCO2
  2. BOSTON CHILDREN'S HOSPITAL1
  3. BOSTON UNIVERSITY MEDICAL CAMPUS1
  4. FLORIDA STATE UNIVERSITY1
  5. HARVARD MEDICAL SCHOOL1
Competing awards under PAR-23-119 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2025An automatic deep learning platform for kidney transmission electron microscopy image analysis1R21DK143406-01LU, WEININGZHANG, CHAOBOSTON UNIVERSITY MEDICAL CAMPUS, MA$478,011EITA
2025Transformation of a human iPSC-derived bone marrow organoid for the study of hematopoiesis1R21DK142111-01MACHLUS, KELLIE RAEBOSTON CHILDREN'S HOSPITAL, MA$469,042BBHV
2025Revolutionizing Renal Histopathology: Integrating Multiplexed Immunofluorescence and ML/AI Image-Based Biomarkers for Precision Diagnosis and Patient Stratification1R21DK143419-01SANTAGATA, SANDROHARVARD MEDICAL SCHOOL, MA$464,750EITA
2025Leverage kidney progenitor plasticity to direct the engineering of next-generation kidney organoid1R21DK144826-01LI, ZHONGWEIUNIVERSITY OF SOUTHERN CALIFORNIA, CA$445,870KUFD
2025Leveraging “Smart Stent” Platform Technologies for AVF Maturation and More1R21DK144827-01ROY-CHAUDHURY, PRABIRSCHULZ, MARKUNIV OF NORTH CAROLINA CHAPEL HILL, NC$437,010KUFD
2025Animal model and resource development for preclinical lower urinary tract research1R21DK140694-01A1HOKANSON, JAMES ARTHURMEDICAL COLLEGE OF WISCONSIN, WI$432,625KUFD
2025Lumbricus terrestris erythrocruorin (LtEc) as a red blood cell substitute in normothermic ex vivo kidney perfusion1R21DK143430-01STOLLER, MARSHALLYANG, HEIKO HUIUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$423,017HTBT
2025Submicron-Resolution Integrated Spatial Transcriptomics and Proteomics for Studying Kidney Disease1R21DK144657-01GU, LIANGCAIUNIVERSITY OF WASHINGTON, WA$404,883ZRG1
2025Cellular tools for studying PKD1 regulation in autosomal dominant polycystic kidney disease1R21DK143398-01LARSON, ERIKWESTERN MICHIGAN UNIV SCHOOL OF MEDICINE, MI$342,002PBKD
2024Measuring kidney NaCl transport in vivo with genetically encoded sensors1R21DK142082-01ORTIZ, PABLO A.WAYNE STATE UNIVERSITY, MI$400,820KUFD
2024Development of stretchable optical sensors for measurement of penile hemodynamics1R21DK142129-01LAFAVOR, JUSTIN DAVIDYU, ZHIBINFLORIDA STATE UNIVERSITY, FL$399,613KUFD
2024Development of selective degradation strategies towards mutant transcription factors1R21DK139543-01A1BIEKER, JAMES JICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$253,500DMPB
2024Developing Danionella cerebrum as an adult vertebrate model to study kidney disease1R21DK139449-01LAM, PUI YINGMANGOS, STEVERUSH UNIVERSITY MEDICAL CENTER, IL$250,561PBKD
2024Targeted ablation of bladder-resident uropathogenic bacteria with a novel cell penetrating dye1R21DK140688-01DE NISCO, NICOLE JANELLGASSENSMITH, JEREMIAH J.UNIVERSITY OF TEXAS DALLAS, TX$249,951KUFD
2024Development of novel genetic tools for the study of type IV collagens1R21DK140866-01GOULD, DOUGLASUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$246,000PBKD
2024Novel methods for detection of mosaic chromosomal alterations1R21DK142089-01WILSON, PARKER C.ZHANG, NANCY RUNIVERSITY OF PENNSYLVANIA, PA$243,750GCAT
2024Nephrogenesis on a chip: an simple modular platform to spatially pattern extracellular matrix, stromal cells, and soluble factors1R21DK142145-01GLEGHORN, JASON PAULUNIVERSITY OF DELAWARE, DE$238,184KUFD
2024Noninvasive Measurement of Voxelwise Renal Oxygenation Using Quantitative Susceptibility Mapping1R21DK137146-01A1KEE, YOUNGWOOKSLOAN-KETTERING INST CAN RESEARCH, NY$220,000ITD
2024Intravesical genome editing in urothelium1R21DK139437-01WU, XUE-RUNEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY$207,000KUFD
2024Constructing Mouse and Human Single-cell Atlas in Autosomal Dominant Polycystic Kidney Disease1R21DK140693-01MA, ANJUNZIMMERMAN, KURT AUNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR, OK$135,582PBKD

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

PAR-23-119: Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed) | ScienceDex | ConductScience